Travere Therapeutics’ Filspari (sparsentan) Receives the US FDA’s Full Approval for Treating IgA Nephropathy
Shots: The US FDA has granted full approval to Filspari (400mg) for treating IgAN,...
Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma
Shots: The US FDA has granted orphan drug designation to the company’s certe...
Vivet Therapeutics’ VTX-806 Receives the EC’s Orphan Drug Designation for Cerebrotendinous Xanthomatosis (CTX)
Shots: The EC has granted orphan drug designation to VTX-806, an adeno-associated...
KalVista Reports the US FDA’s NDA Acceptance of Sebetralstat for Treating Hereditary Angioedema (HAE)
Shots: The US FDA has accepted NDA for sebetralstat to treat HAE (PDUFA: Jun 17, 2...
Grit Biotechnology Reports the US FDA’s IND Approval of GT201 for Treating Advanced Solid Tumors
Shots: The US FDA has granted clearance to the company’s IND application for...
Pierre Fabre Laboratories Reports the EC’s Approval of Braftovi Plus Mektovi to Treat Advanced Non-Small Cell Lung Cancer
Shots: The EC has approved Braftovi + Mektovi to treat advanced NSCLC adults with...
